Table 1.
Clinical characteristics of the entire population and according to all-cause mortality.
| Variables | All patients N = 245 |
All-cause mortality | p | |
|---|---|---|---|---|
| No n = 201 |
Yes n = 44 |
|||
| Age (years) | 63.7 ± 13.1 | 62.5 ± 12.8 | 69.3 ± 13.4 | 0.002 |
| Male | 159 (64.9%) | 134 (66.7%) | 25 (56.8%) | 0.215 |
| Hypertension | 161 (67.1%) | 129 (65.5%) | 32 (74.4%) | 0.259 |
| Diabetes | 68 (28.3%) | 53 (26.9%) | 15 (34.9%) | 0.293 |
| Dyslipidemia | 71 (29.6%) | 57 (28.9%) | 14 (32.6%) | 0.637 |
| Current smoker | 85 (34.7%) | 65 (32.3%) | 20 (45.4%) | 0.096 |
| Family history of CAD | 49 (20.4%) | 42 (21.3%) | 7 (16.3%) | 0.458 |
| Killip ≥ II | 41 (17.7%) | 18 (9.6%) | 23 (53.5%) | < 0.001 |
| GRACE score | 114 (92–131) | 110 (90–125) | 141 (123.25–170.25) | < 0.001 |
| Systolic blood pressure (mmHg) | 133.3 ± 33.2 | 135.5 ± 31.4 | 124.5 ± 34.1 | 0.047 |
| Diastolic blood pressure (mmHg) | 82.7 ± 17.9 | 84.1 ± 17.6 | 77.3 ± 18.7 | 0.028 |
| Heart rate | 79.9 ± 19.8 | 78.0 ± 18.8 | 87.3 ± 21.9 | 0.007 |
| LVEF | 54.2 ± 11.3 | 55.2 ± 10.9 | 43.1 ± 10.1 | 0.001 |
| Anterior STEMI | 115 (47.1%) | 91 (45.5%) | 24 (54.5%) | 0.276 |
| Total ischemic time (min) | 430 (290–625) | 433 (291–629) | 402 (263–512) | 0.328 |
| CA125 (IU/mL) | 8.1 (5.7–12.1) | 8.0 (5.5–11.2) | 9.2 (6.4–14.5) | 0.056 |
| NTproBNP (pg/mL) | 828.6 (202–2,374) | 783.1 (184–2,117) | 1,418.0 (302–7,714) | 0.013 |
| hs-CRP (mg/dL) | 0.50 (0.25–1.76) | 0.48 (0.22–1.45) | 0.81 (0.36–5.57) | 0.004 |
CAD coronary artery disease, LVEF left ventricle ejection fraction, STEMI ST-segment elevation myocardial infarction, CA125 carbohydrate antigen 125, NTproBNP N-terminal pro brain natriuretic peptide, hs-CRP high sensitive C-reactive protein, GRACE risk global registry of acute coronary events.